David A. Siegel Moderna, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Moderna, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 103,700 shares of MRNA stock, worth $3.65 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,700
Previous 356,500
70.91%
Holding current value
$3.65 Million
Previous $23.8 Million
81.9%
% of portfolio
0.01%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding MRNA
# of Institutions
924Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.42 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.37 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$900 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$619 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$257 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...